Folkstone, United Kingdom

Richard Storer


Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 582(Granted Patents)


Company Filing History:


Years Active: 2007-2009

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Richard Storer: Pioneering Prodrugs for Viral Infections

Introduction

Richard Storer is a notable inventor based in Folkstone, GB, recognized for his significant contributions to the field of pharmaceuticals through his innovative work on nucleoside prodrugs. With a total of seven patents to his name, Storer has focused his research on developing effective treatments for viral infections, particularly those caused by Flaviviridae family viruses.

Latest Patents

Storer's latest patents revolve around "Modified 2' and 3'-nucleoside prodrugs for treating infections." These patents describe 2' and/or 3'-prodrugs of 1', 2', 3', or 4'-branched nucleosides and their pharmaceutically acceptable salts and derivatives. His inventions target the prevention and treatment of infections from the Flaviviridae family, notably Hepatitis C virus (HCV) and other related conditions. The described compounds and compositions offer methods and uses for the administration of an effective dosage of these prodrugs, which may also be combined with other antiviral agents to enhance treatment efficacy.

Career Highlights

Throughout his career, Richard Storer has been affiliated with prominent organizations in the pharmaceutical industry, including Idenix Pharmaceuticals, Inc., and the Centre National De La Recherche Scientifique. His work in these organizations has allowed him to contribute extensively to cutting-edge research focused on antiviral therapies and nucleoside chemistry.

Collaborations

Storer worked alongside esteemed colleagues Gilles Gosselin and Jean-Pierre Sommadossi. These collaborations have propelled his advancements in the field and have led to innovative approaches in treating viral infections, showcasing the importance of teamwork in scientific research.

Conclusion

Richard Storer stands out as a key player in the invention of novel prodrugs, demonstrating dedication and innovation in addressing significant health challenges posed by viral infections. His patents and collaborations mark substantial progress in antiviral treatment research, underscoring his importance as an inventor in the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…